MedPath

Amgen Europe BV

🇳🇱Netherlands
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.amgen.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

SFDA:6
EMA:4

Drug Approvals

Lumykras

Authorization Status
Authorised
Approval Date
Jan 6, 2022
EMA

Kanjinti

Authorization Status
Authorised
Approval Date
May 16, 2018
EMA

Otezla

Authorization Status
Authorised
Approval Date
Jan 15, 2015
EMA

Otezla

Authorization Status
Authorised
Approval Date
Jan 15, 2015
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.